Conneqt Health Limited has released a press release.
Convertible Note Facility and Dual Listing Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Conneqt Health
- Corporate Update
- CardieX receives FDA 510(k) Clearance for CONNEQT Pulse
- CardieX Completes Capital Raising
- CardieX Announces Significant New Clinical Trial Agreement
- CardieX Acquires Core Assets from Blumio, Inc
Later from Conneqt Health
- CardieX Files Form F-1 to Dual List on US Nasdaq Exchange
- Nasdaq IPO & Dual Listing Update
- Convertible Note Facility Update
- Withdrawal of F-1 Registration Statement
- Suspension from Official Quotation
Follow Conneqt Health into a list and get an email when it puts out news.
Follow Conneqt Health